Related Experiment Video
Updated: Aug 24, 2025

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Management of Coronary Artery Disease in the Setting of Transcatheter Aortic Valve Replacement
Natraj Katta1, J Dawn Abbott2, Ankur Kalra3
1University of Nebraska Medical Center, Omaha, NE, USA.
Insights
The best way to treat coronary artery disease (CAD) in patients undergoing transcatheter aortic valve replacement (TAVR) is unclear. More research is needed to determine if CAD revascularization improves outcomes after TAVR.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Aortic stenosis and coronary artery disease (CAD) often coexist due to shared risk factors and pathophysiology.
- Optimal management of CAD in patients undergoing transcatheter aortic valve replacement (TAVR) is uncertain due to limited evidence.
Purpose of the Study:
- To review the current evidence regarding CAD revascularization in patients undergoing TAVR.
- To highlight the need for further research, specifically randomized controlled trials (RCTs), to guide clinical decision-making.
Main Methods:
- Review of observational studies and meta-analyses on outcomes of CAD revascularization in TAVR patients.
- Analysis of factors influencing outcomes, such as residual SYNTAX score (rSS).
Main Results:
- Existing studies show varied results; no significant difference in post-TAVR outcomes between revascularized and non-revascularized patients.
- Some evidence suggests lower rSS post-revascularization may correlate with better TAVR outcomes.
Conclusions:
- The benefit of CAD revascularization in TAVR patients remains inconclusive.
- Individualized treatment decisions based on heart team consultation are recommended in the absence of definitive RCT data.
Abstract:
Aortic stenosis and coronary artery disease (CAD) frequently co-exist, as they share a common pathophysiology and risk factors. Due to lack of randomised controlled trials (RCTs) and exclusion of significant CAD in transcatheter aortic valve replacement (TAVR) trials, the optimal method of revascularisation of CAD in patients undergoing TAVR remains unknown. Observational studies and meta-analyses have shown varied results in outcomes for patients with CAD undergoing TAVR, and no significant difference in post-TAVR outcomes in patients who underwent revascularisation either prior to or during TAVR versus those who did not. However, some observational studies have shown that patients with lower residual SYNTAX score (rSS) post-revascularisation have better outcomes post-TAVR compared to those with higher rSS. RCTs are needed to clearly understand whether revascularisation is beneficial in these patients. Until then, management of CAD in patients undergoing TAVR must be individualised based on discussion with the heart team.
More Related Videos
06:59Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
Published on: June 3, 2018
12:17Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Related Concept Videos
Aortic Regurgitation III: Medical Management
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Atherosclerosis III: Management
Angina IV: Management
Aortic Regurgitation IV: Nursing Management